Tango Therapeutics (TNGX) EPS (Basic) (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly EPS (Basic) of -$0.32 for Q1 2026, up 12.31% year-over-year from -$0.28 in Q1 2025, and up 4.96% quarter-over-quarter from -$0.33 in Q4 2025.
Powered by 
Analysis
Tango Therapeutics (TNGX) EPS (Basic) (2020 - 2026) Analysis & Trends
Tango Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.32 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 12.31% year-over-year to -$0.32; the TTM figure through Mar 2026 stood at -$0.75 (up 37.72% YoY), while the FY2025 annual figure was -$0.87, up 26.69% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.32, up from -$0.33 in the prior quarter.
- The five-year high for EPS (Basic) was $0.14 in Q3 2025, with the low at -$0.36 in Q1 2025.
- The 5-year median for EPS (Basic) is -$0.32 (2023), against an average of -$0.28.
- Peak annual rise in EPS (Basic) reached 153.25% in 2025, while the deepest fall reached 49.0% in 2025.
- Tango Therapeutics' EPS (Basic) stood at -$0.33 in 2022, then increased by 1.96% to -$0.32 in 2023, then declined by 6.14% to -$0.34 in 2024, then climbed by 3.28% to -$0.33 in 2025, then increased by 4.96% to -$0.32 in 2026.
- Business Quant data shows TNGX's EPS (Basic) at -$0.32 in Q1 2026, -$0.33 in Q4 2025, and $0.14 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Tango Therapeutics | 3.37 Bn | 2.35 Bn | - | -0.37 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.37 |
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -0.15 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | -0.35 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | -0.34 |
| Sep 30, 2024 | -0.27 |
| Jun 30, 2024 | -0.24 |
| Mar 31, 2024 | -0.35 |
| Dec 31, 2023 | -0.33 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.23 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.33 |
| Sep 30, 2022 | -0.33 |
| Jun 30, 2022 | -0.28 |
| Mar 31, 2022 | -0.29 |
| Dec 31, 2021 | -0.36 |
| Sep 30, 2021 | -0.28 |